NIT
BPMC

NumerixS Investment Technologies’s Blueprint Medicines BPMC Stock Holding History

NumerixS Investment Technologies’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-568
Closed -$46K – 1015
2019
Q4 		$46K Buy
+568
New +$42.5K 0.01% 831
2019
Q2 		– Sell
-400
Closed -$30K – 1085
2019
Q1 		$30K Buy
+400
New +$29.6K ﹤0.01% 1046
2018
Q4 		– Sell
-4,100
Closed -$321K – 1094
2018
Q3 		$321K Sell
4,100
-1,000
-20% -$69.5K 0.06% 420
2018
Q2 		$311K Buy
5,100
+4,500
+750% +$358K 0.07% 392
2018
Q1 		$52K Buy
+600
New +$51.7K 0.01% 795
2017
Q4 		– Sell
-1,700
Closed -$118K – 1144
2017
Q3 		$118K Buy
+1,700
New +$90.8K 0.03% 696
2017
Q2 		– Sell
-16,604
Closed -$664K – 1141
2017
Q1 		$664K Buy
16,604
+12,880
+346% +$461K 0.08% 320
2016
Q4 		$104K Buy
+3,724
New +$112K 0.01% 849

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NumerixS Investment Technologies's BPMC Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Blueprint Medicines (BPMC) in Q1 2020, closing a stake of 568 shares — an estimated $46K sold.

NumerixS Investment Technologies first reported a position in BPMC in Q4 2016 and held it in 8 quarters. The position peaked at $664K in Q1 2017. 213 funds tracked by Wall St. Rank hold BPMC as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Blueprint Medicines position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 568 Blueprint Medicines shares in Q1 2020, an estimated $46K.
  • NumerixS Investment Technologies first reported a position in Blueprint Medicines in Q4 2016 and held it in 8 quarters.
  • NumerixS Investment Technologies's Blueprint Medicines position peaked at $664K in Q1 2017.
  • 213 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.